A historical treatment review discussed several mechanisms and adjuncts. Benzodiazepines did not replace treatment of the wider cholinergic syndrome.
The review covered atropine, oximes, respiratory support, seizure control, and investigational approaches. Benzodiazepines appeared within the neurologic-treatment discussion rather than as an antidote for every organophosphate effect.
The paper also described limits of cholinesterase measurements, including baseline variation and the effect of time on retrospective exposure assessment.
Controlling convulsions is distinct from reversing muscarinic manifestations, restoring neuromuscular function, or preventing delayed neuropathology. An apparently improved examination does not establish that all toxic effects have resolved.
This is a review from its publication period, with experimental and clinical evidence of differing strength. It cannot supply an individualized modern regimen or prove that one adjunct would have prevented a death. For a case review, preserve exposure identity, treatment delay, airway care, seizure measurements, and the separate objectives of each intervention.
Original analysis of the supplied journal article, identified as PMC3470074.